Logo image
Ribose-5-phosphate isomerase A overexpression promotes liver cancer development in transgenic zebrafish via activation of ERK and β-catenin pathways
期刊文章   開放取用(OA)

Ribose-5-phosphate isomerase A overexpression promotes liver cancer development in transgenic zebrafish via activation of ERK and β-catenin pathways

Y.-T. Chou, L.-Y. Chen, S.-L. Tsai, H.-C. Tu, J.-W. Lu, S.-C. Ciou, H.-D. Wang 和 C.-H. Yuh
Carcinogenesis, 卷.40(3), 頁碼.461-473
2019
Web of Science ID: WOS:000472794100008

摘要

Aldose-Ketose Isomerases Animals Animals, Genetically Modified beta Catenin Cell Line, Tumor Disease Progression Extracellular Signal-Regulated MAP Kinases Liver Neoplasms, Experimental Zebrafish beta catenin isomerase mitogen activated protein kinase ribose 5 phosphate beta catenin isomerase mitogen activated protein kinase ribosephosphate isomerase animal experiment animal model animal tissue Article cancer growth carcinogenesis cell proliferation comparative study controlled study enzyme activation fatty liver human human cell liver cell carcinoma liver fibrosis nonhuman priority journal real time polymerase chain reaction reverse transcription polymerase chain reaction signal transduction transgenic zebrafish xenotransplantation animal disease exacerbation enzymology experimental liver neoplasm genetics metabolism pathology transgenic animal tumor cell line zebra fish
Dysregulation of the enzymes involved in the pentose phosphate pathway (PPP) is known to promote tumorigenesis. Our recent study demonstrated that ribose-5-phosphate isomerase (RPIA), a key regulator of the PPP, regulates hepatoma cell proliferation and colony formation. Our studies in zebrafish reveal that RPIA-mediated hepatocarcinogenesis requires extracellular signal-regulated kinase (ERK) and β-catenin signaling. To further investigate RPIA-mediated hepatocarcinogenesis, two independent lines of transgenic zebrafish expressing human RPIA in the liver were generated. These studies reveal that RPIA overexpression triggers lipogenic factor/enzyme expression, steatosis, fibrosis and proliferation of the liver. In addition, the severity of fibrosis and the extent of proliferation are positively correlated with RPIA expression levels. Furthermore, RPIA-mediated induction of hepatocellular carcinoma (HCC) requires the ERK and β-catenin signaling pathway but is not dependent upon transaldolase levels. Our study presents a mechanism for RPIA-mediated hepatocarcinogenesis and suggests that RPIA represents a valuable therapeutic target for the treatment of HCC. © 2019 The Author(s).

檔案與連結 (2)

url
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066817959&doi=10.1093%2fcarcin%2fbgy155&partnerID=40&md5=ecb49c17cd106e9f24087ea30fb2b7f1檢視
url
https://doi.org/10.1093/carcin/bgy155檢視
已出版(紀錄版本) 開放

相關連結

InCites亮點

本研究成果之相關指標(擷取自 InCites Benchmarking & Analytics)

合作類型
機構合作
國際合作
引用書目主題
1 Clinical & Life Sciences
1.25 Molecular & Cell Biology - Cancer, Autophagy & Apoptosis
1.25.1473 Cancer Metabolism
Web Of Science研究領域
Oncology
ESI研究領域
Clinical Medicine

聯合國永續發展目標(SDGs)

此研究成果有助於達成以下目標:

#3 Good Health and Well-Being

來源:來自InCites的SDGs

詳細資料

Logo image